These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 3531149)
1. Comparison of two new controlled-release theophylline formulations in the management of asthma in children and reliability of salivary theophylline concentration. Boner AL; Bennati D; Miglioranzi P; Gaburro D J Asthma; 1986; 23(4):195-202. PubMed ID: 3531149 [TBL] [Abstract][Full Text] [Related]
2. Reliability of salivary theophylline concentration monitoring in children with bronchial asthma following the administration of different drug formulations. Boner AL; Valletta EA; Plebani M; Biancotto R; Bellanti JA Allergol Immunopathol (Madr); 1985; 13(5):393-8. PubMed ID: 4083233 [TBL] [Abstract][Full Text] [Related]
3. Oral bioavailability of slow-release theophylline from unencapsulated beads in preschool children with chronic asthma. Vaughan LM; Milavetz G; Weinberger MM; Smith GD; Harris JB Ther Drug Monit; 1988; 10(4):395-400. PubMed ID: 3059587 [TBL] [Abstract][Full Text] [Related]
4. Salivary theophylline estimation in the management of asthma in children. Lena SM; Hutchins P; Wood CB; Turner P Postgrad Med J; 1980 Feb; 56(652):85-7. PubMed ID: 7393801 [TBL] [Abstract][Full Text] [Related]
5. [Slow-release theophyllines: serum and saliva levels in asthmatic children]. Souto Martínez I; Duque Hernández J; Galván Tudela L; Alvarez Sanz E; Díaz Gómez MI An Esp Pediatr; 1988 Jun; 28(6):513-6. PubMed ID: 3195854 [TBL] [Abstract][Full Text] [Related]
6. Theophylline absorption in young asthmatic children receiving sustained-release formulations. Haltom JR; Szefler SJ J Pediatr; 1985 Nov; 107(5):805-10. PubMed ID: 4056986 [TBL] [Abstract][Full Text] [Related]
7. Saliva and serum theophylline concentration in management of asthma in children on sustained-release therapy. Iwasaki E; Baba M J Asthma; 1987; 24(3):173-8. PubMed ID: 3505531 [TBL] [Abstract][Full Text] [Related]
9. Theophylline concentrations in serum and saliva after oral microcrystalline and sustained-release preparations in asthmatics. Munch EP; Søndergaard I; Weeke B Allergy; 1981 Feb; 36(2):89-98. PubMed ID: 7235205 [TBL] [Abstract][Full Text] [Related]
10. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children. Logvinoff MM; Weinstein DB; Watts MT; Seifert B Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of passively absorbed saliva for determination of oral slow-release theophylline bioavailability in children. Vaughan LM; Milavetz G; Weinberger MM; Smith GD; Merrick JG Drug Intell Clin Pharm; 1988 Sep; 22(9):684-7. PubMed ID: 3215109 [TBL] [Abstract][Full Text] [Related]
12. Monitoring children on sustained-release therapy by salivary theophylline levels. Kelly HW; Hadley WM; Murphy SA; Skipper BG Am J Dis Child; 1981 Feb; 135(2):137-9. PubMed ID: 7468545 [TBL] [Abstract][Full Text] [Related]
13. Monitoring of theophylline treatment by saliva and plasma concentrations. Juntunen-Backman K; Backman A; Björkstén F; Finnilä MJ Allergol Immunopathol (Madr); 1988; 16(1):5-9. PubMed ID: 3381714 [TBL] [Abstract][Full Text] [Related]
14. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma. Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832 [TBL] [Abstract][Full Text] [Related]
15. A controlled comparison of slow-release theophylline, ketotifen and placebo in the prophylaxis of asthma in young children. Carswell F; Stratton D; Hughes AO; Fysh WJ; Robinson P Agents Actions Suppl; 1983; 13():141-4. PubMed ID: 6346833 [TBL] [Abstract][Full Text] [Related]
16. Compliance of chronic asthmatics with oral administration of theophylline as measured by serum and salivary levels. Eney RD; Goldstein EO Pediatrics; 1976 Apr; 57(4):513-7. PubMed ID: 1264547 [TBL] [Abstract][Full Text] [Related]
17. [Slow-release theophylline for the treatment of asthmatic children]. Iwasaki E; Baba M Nihon Rinsho; 1996 Nov; 54(11):3102-7. PubMed ID: 8950962 [TBL] [Abstract][Full Text] [Related]
18. Absolute and relative bioavailability of a slow release theophylline preparation in asthmatic children. Boner AL; De Stefano G; Vallone G; Plebani M; Ventura P J Int Med Res; 1987; 15(5):282-92. PubMed ID: 3678595 [TBL] [Abstract][Full Text] [Related]
19. [The monitoring of delayed-release theophylline therapy in bronchial asthma in children by determining the salivary concentration]. Panta P; Nanulescu MV; Culea M; Palibroda N Pneumoftiziologia; 1998; 47(1):15-9. PubMed ID: 9932029 [TBL] [Abstract][Full Text] [Related]
20. Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthma. Williams PE; Alwazir YA; Routledge PA; Campbell IA Br J Clin Pharmacol; 1986 Oct; 22(4):383-7. PubMed ID: 3768254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]